Asia / TAIWAN
Company Overview
Obigen Pharma, Inc. operates as a biopharmaceutical company that develops and manufactures botulinum toxin products. The company was founded on December 10, 2010 and is headquartered in Taipei, Taiwan.
Obigen Pharma, Inc. operates as a biopharmaceutical company that develops and manufactures botulinum toxin products. The company was founded on December 10, 2010 and is headquartered in Taipei, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Biological Products Exc. Diagnostic |
| Country | TAIWAN |
| Employees | n/a |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Wright ID | C158TTY58 |
Key Metrics
| Current price | $60.20 |
| Market cap | $7.22 B |
| P/E ratio | n/a |
| Common shares | 119.9 M |
| Share type | Gu |
| Quality rating | LBD0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | -1.5% |
| 4 Week | -1.7% |
| 13 Week | +75.3% |
Officers
n/a
Address
TAIWAN
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.